Sarah Ketterer
Causeway Capital Management
Sarah Ketterer AstraZeneca PLC stake
total: 372
Causeway Capital Management AZN trades
- Total transactions:
- 2
- New positions:
- 1
- Added:
- 1
- Held since:
- 2026 Q1
- Held for:
- 2 quarters
- Latest activity:
- 2026 Q2
According to 2026 Q2 report, Sarah Ketterer holds 9,357,390 AstraZeneca PLC (AZN) shares with a market value of roughly $1.75B accounting for 18.97% of the overall portfolio. To date, the estimated cost basis is nearly $192.42 for "buy" trades. Causeway Capital Management first purchased AZN in 2026 Q1, initially acquiring about 7.42M shares. Since the initial investment in AstraZeneca PLC (AZN), Causeway Capital Management has made 1 more transaction.
When did Sarah Ketterer buy AstraZeneca PLC (AZN)?
Sarah Ketterer first invested in AstraZeneca PLC (AZN) in 2026 Q1 at the reported quarter-end price of $193.78 per share.
What's the cost basis of Causeway Capital Management's AZN stake?
The estimated cost basis for AstraZeneca PLC (AZN) stake is around $192.42 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $192.42
Sarah Ketterer's historical trades in AstraZeneca PLC
2 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q2
|
18.97%
|
9,357,390
|
$187.18
|
$1,751,546,442
|
+26.08% (+1,935,641)
|
+3.92%
|
|
2026 Q1
|
17.66%
|
7,421,749
|
$193.78
|
$1,438,217,252
|
new
|
+17.66%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.